| Literature DB >> 28478517 |
Mohammad Ali Amirzargar1, Faramarz Yaghubi1, Mohammad Hosseinipanah2, Mohammad Jafari3, Mona Pourjafar4, Mahsa Rezaeepoor4, Hamzeh Rezaei4, Godratollah Roshanaei5, Mehrdad Hajilooi4, Ghasem Solgi6.
Abstract
Valporic acid (VPA) has been implicated to have anti-inflammatory and anti-oxidant activities in several ischemic/reperfusion (I/R) injury models. This study intended to evaluate whether VPA could affect the inflammatory/anti-inflammatory cytokines balance and severity of renal I/R injury in rat. I/R injury was induced in two groups of animals, vehicle normal saline and VPA-treated (IP injection, 150 mg/kg) rats, by 45 min occlusion of both left and right renal arteries followed by 3, 24 and 120 h reperfusion in separate groups. After each time point, kidneys and blood samples were collected for cytokine genes (TNF-α, IL-1β, IL-10 and TGF-β) expression analysis and histological examinations in the kidney tissues. Serum creatinine levels were measured for evaluation of renal function. We observed significantly downregulated mRNA expressions for IL-1β and TNF-α in blood and tissue samples 24 and 120 h post I/R injury in VPA-treated animals compared to control groups (P < 0.0001). On the other hand, mRNA expression levels for IL-10 and TGF-β were significantly increased in the blood samples from VPA-treated animals at two time points after I/R injury (P < 0.0001) and at 120 h in tissue samples (P < 0.001). Histopathology analysis showed downgraded ischemic changes in VPA group compared to sham control. Also, decreased serum creatinine levels were observed in VPA-treated animals particularly 120 h post I/R injury (P < 0.0001) that was correlated with less pathological changes in this group. Our results indicate that VPA can attenuate pro-inflammatory responses and augment the anti-inflammatory condition in favor of faster renal recovery from ischemic changes and improved renal function after renal I/R injury.Entities:
Keywords: interleukin-10; interleukin-1β; renal ischemia/reperfusion; transforming growth factor-β; tumor necrosis factor-α; valproic acid
Mesh:
Substances:
Year: 2017 PMID: 28478517 DOI: 10.1007/s10753-017-0574-9
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092